The International Association of Cystic Fibrosis Adults Newsletter
Applications of genetic information regarding the gene responsible for cystic fibrosis (Part 1). The International Association of Cystic Fibrosis Adults Newsletter. 1994; (40):3-8.
Applications of genetic information regarding the gene responsible for cystic fibrosis (Part 1)
Non-sedation of the neonate for radiologic procedures. Pediatr Radiol. 2018 04; 48(4):524-530.
Non-sedation of the neonate for radiologic procedures.
Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB
Challenges in implementing a successful newborn cystic fibrosis screening program. J Pediatr. 2005 Sep; 147(3 Suppl):S89-93.
Challenges in implementing a successful newborn cystic fibrosis screening program.
Bronchopulmonary dysplasia. Curr Opin Pediatr. 1990; (2):459-464.
Parad R, Davis J, Marlow N, Peacock J, Calvert S, Greenough A
A Chronic Respiratory Morbidity (CRM) Definition Derived from 12 Month (M) Respiratory Symptom Diaries (RD) Predicts 12m Pulmonary Function (PFT) and 24m Respiratory Health in Extremely Low Gestational Age Newborns (ELGANs). Ped Research. 2009.
A Chronic Respiratory Morbidity (CRM) Definition Derived from 12 Month (M) Respiratory Symptom Diaries (RD) Predicts 12m Pulmonary Function (PFT) and 24m Respiratory Health in Extremely Low Gestational Age Newborns (ELGANs)
Neonatology Core Curriculum, Volume III (2008 edition)
Neonatology Core Curriculum, Volume III (2008 edition). 1991.
Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ
Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr. 2009 Dec; 155(6 Suppl):S106-16.
Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond.
Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ
Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009 Dec; 155(6 Suppl):S73-93.
Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.
HFOV in preterms: an individual patients' data meta-analysis. Lancet. 2010 Jun 12; 375(9731):2054-5.
HFOV in preterms: an individual patients' data meta-analysis.
Nathe KE, Mancuso CJ, Parad R, Van Marter LJ, Martin CR, Stoler-Barak L, Philbin VJ, Phillips MF, Palmer CD, Levy O
Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation. Pediatr Res. 2012 Aug; 72(2):203-11.
Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation.
Nathe K, Stoler-Barak L, Philbin V, Parad R, Van Marter L, Levy O
Early Activation of an Innate Immune Transcriptome and Identification of Calgranulin C Expression. Ped Research. 2009.
Early Activation of an Innate Immune Transcriptome and Identification of Calgranulin C Expression
Murry JB, Machini K, Ceyhan-Birsoy O, Kritzer A, Krier JB, Lebo MS, Fayer S, Genetti CA, VanNoy GE, Yu TW, Agrawal PB, Parad RB, Holm IA, McGuire AL, Green RC, Beggs AH, Rehm HL
Cold Spring Harbor molecular case studies
Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report. Cold Spring Harb Mol Case Stud. 2018 08; 4(4).
Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report.
AP IMPACT: Testing curbs some genetic diseases (Associated Press interview by Marilynn Marchione): http://www.npr.org/templates/story/story.php?storyId=123798798 http://abcnews.go.com/Technology/wireStory?id=9877649 http://news.yahoo.com/s/ap/20100218/ap_on_sc/us_med_gene_testing http://www.washingtonpost.com/wp-dyn/content/article/2010/02/21/AR2010022101704.html http://www.foxnews.com/story/0,2933,586331,00.html,http://www.cnbc.com/id/35369312/ http://www.nytimes.com/aponline/2010/02/18/science/AP-US-MED-Gene-Testing.html?ref=aponline
AP IMPACT: Testing curbs some genetic diseases (Associated Press interview by Marilynn Marchione): http://www.npr.org/templates/story/story.php?storyId=123798798 http://abcnews.go.com/Technology/wireStory?id=9877649 http://news.yahoo.com/s/ap/20100218/ap_on_sc/us_med_gene_testing http://www.washingtonpost.com/wp-dyn/content/article/2010/02/21/AR2010022101704.html http://www.foxnews.com/story/0,2933,586331,00.html,http://www.cnbc.com/id/35369312/ http://www.nytimes.com/aponline/2010/02/18/science/AP-US-MED-Gene-Testing.html?ref=aponline. 2010.
Prenatal Care (McCormick MC, Siegel JE, editors)
Developing fetal diagnostic techniques. Prenatal Care (McCormick MC, Siegel JE, editors). 1999; 231-243.
Baby's first test: Newborn Screening. 2008.
Sontag MK, Sarkar D, Comeau AM, Hassell K, Botto LD, Parad R, Rose SR, Wintergerst KA, Smith-Whitley K, Singh S, Yusuf C, Ojodu J, Copeland S, Hinton CF
International journal of neonatal screening
Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance. Int J Neonatal Screen. 2018; 4(2):16.
Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance.
Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP
Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr. 2005 Sep; 147(3 Suppl):S69-72.
Sweat testing infants detected by cystic fibrosis newborn screening.
Parad RB, Kramer J, Strunk RC, Rosen FS, Davis AE
Proceedings of the National Academy of Sciences of the United States of America
Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site. Proc Natl Acad Sci U S A. 1990 Sep; 87(17):6786-90.
Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.
Ward VL, Barnewolt CE, Estroff JA, Levine D, Mehta TS, Parad RB
Work-in-Progress for the SPR Millennium Grant: Fetal MR of Chest Masses. The Society for Pediatric Radiology. 2003.
Work-in-Progress for the SPR Millennium Grant: Fetal MR of Chest Masses
Estroff J, Wong J, Parad R, Tanden R, Barnewolt C,
Accuracy of Prenatal Imaging of Fetal Cleft Palate by MRI. Presented at IFMSS, Kona, Hawaii. 2006.
Accuracy of Prenatal Imaging of Fetal Cleft Palate by MRI
Levesque B, Hernandez-Diaz S, Parad R, Phillips M, Gupta M, Ingber D, Van Marter L
BPD: Clinical Results Title: Urinary Vascular Endothelial Growth Factor (VEGF): Correlation with Mechanical Ventilation and Bronchopulmonary Dysplasia (BPD) in Infants Born before 29 Weeks Gestation. Ped Research. 2009.
BPD: Clinical Results Title: Urinary Vascular Endothelial Growth Factor (VEGF): Correlation with Mechanical Ventilation and Bronchopulmonary Dysplasia (BPD) in Infants Born before 29 Weeks Gestation
Applications of genetic information regarding the gene responsible for cystic fibrosis (Part 2). The International Association of Cystic Fibrosis Adults Newsletter. 1995; (41):3-9.
Applications of genetic information regarding the gene responsible for cystic fibrosis (Part 2)
Comeau A, Parad RB, Dorkin H, Dovey M, Haver K, Lapey A, Gerstle R, O’Sullivan B
Increased sensitivity at the cost of increased referrals when population-based newborn screening incorporates testing for multiple allele mutations (MM): Cystic Fibrosis (CF) newborn screening (NBS) as a model. Am J Hum Genet. 2003; (73):( 5 sup ): 213.
Increased sensitivity at the cost of increased referrals when population-based newborn screening incorporates testing for multiple allele mutations (MM): Cystic Fibrosis (CF) newborn screening (NBS) as a model
Parad RB, Applegate K, Doubilet PM, Fishman SJ, Estroff JA
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
Occult fetal bowel obstruction: ileal atresia presenting in a newborn infant after normal antenatal sonography. J Ultrasound Med. 1995 Feb; 14(2):161-3.
Occult fetal bowel obstruction: ileal atresia presenting in a newborn infant after normal antenatal sonography.
Parad RB, Comeau AM, Dovey M, Martin T, Dorkin H, O’Sullivan B, Gerstle R
Prevalence of immunoreactive trypsinogen (IRT) level below newborn screen cutoff in CF that presents with meconium ileus. Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, MO. Ped Pulm. 2004; S27:226.
Prevalence of immunoreactive trypsinogen (IRT) level below newborn screen cutoff in CF that presents with meconium ileus. Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, MO
Nguyen RH, Umbach DM, Parad RB, Stroehla B, Rogan WJ, Estroff JA
US assessment of estrogen-responsive organ growth among healthy term infants: piloting methods for assessing estrogenic activity. Pediatr Radiol. 2011 May; 41(5):633-42.
US assessment of estrogen-responsive organ growth among healthy term infants: piloting methods for assessing estrogenic activity.
Holm IA, Agrawal PB, Ceyhan-Birsoy O, Christensen KD, Fayer S, Frankel LA, Genetti CA, Krier JB, LaMay RC, Levy HL, McGuire AL, Parad RB, Park PJ, Pereira S, Rehm HL, Schwartz TS, Waisbren SE, Yu TW, Green RC, Beggs AH
The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018 07 09; 18(1):225.
The BabySeq project: implementing genomic sequencing in newborns.
Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008 Aug; 153(2):S4-S14.
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.
Cystic Fibrosis Newborn Screening. Pediatric Annals. 2003; 32(8):528-35.
An Unexpected Screening Result© (IN703.3)
An Unexpected Screening Result© (IN703.3). 2002.
Als H, Duffy FH, McAnulty GB, Fischer CB, Kosta S, Butler SC, Parad RB, Blickman JG, Zurakowski D, Ringer SA
Journal of perinatology : official journal of the California Perinatal Association
Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) effective for preterm infants with intrauterine growth restriction? J Perinatol. 2011 Feb; 31(2):130-6.
Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) effective for preterm infants with intrauterine growth restriction?
Donation after cardiac death: the potential contribution of an infant organ donor population. J Pediatr. 2011 Jan; 158(1):31-6.
Donation after cardiac death: the potential contribution of an infant organ donor population.
Genetti CA, Schwartz TS, Robinson JO, VanNoy GE, Petersen D, Pereira S, Fayer S, Peoples HA, Agrawal PB, Betting WN, Holm IA, McGuire AL, Waisbren SE, Yu TW, Green RC, Beggs AH, Parad RB
Genetics in medicine : official journal of the American College of Medical Genetics
Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. Genet Med. 2019 03; 21(3):622-630.
Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project.
Welty S, Lynch S, O’Shea TM, Malcolm W, Kallapur S, Auten R, Martin R,Truog W, Nelin L, Nogee L, Parad RB, Abman S, Bancalari E, Walsh M.
2009 BPD Roundtable: http://www.nationwidechildrens.org/bpd-roundtable
2009 BPD Roundtable: http://www.nationwidechildrens.org/bpd-roundtable. 2009.
Davis JM, Rosenfeld W, Richter SE, Parad RB, Gewolb IH, Spitzer A, Carlo W, Couser R, Price A, Flaster E, Kassem N, Edwards L, Tierney J, Horowitz S.
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics. 1997; 100:24-30.
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome
Parad RB, Winston AB, Kalish LA, Gupta M, Thompson I, Sheldon Y, Morey J, Van Marter LJ
Role of Genetic Susceptibility in the Development of Bronchopulmonary Dysplasia. J Pediatr. 2018 12; 203:234-241.e2.
Role of Genetic Susceptibility in the Development of Bronchopulmonary Dysplasia.
Estroff JA, Parad RB, Barnes PD, Madsen JP, Benacerraf BR
Posterior fossa arachnoid cyst: an in utero mimicker of Dandy-Walker malformation. J Ultrasound Med. 1995 Oct; 14(10):787-90.
Posterior fossa arachnoid cyst: an in utero mimicker of Dandy-Walker malformation.
Newborn screening showing decreasing incidence of cystic fibrosis. N Engl J Med. 2008 Feb 28; 358(9):973-4.
Newborn screening showing decreasing incidence of cystic fibrosis.
Ariga T, Igarashi T, Ramesh N, Parad R, Cicardi M, Davis AE
Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon. J Clin Invest. 1989 Jun; 83(6):1888-93.
Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon.
Estroff JA, Parad RB, Share JC, Benacerraf BR
Second trimester prenatal findings in duodenal and esophageal atresia without tracheoesophageal fistula. J Ultrasound Med. 1994 May; 13(5):375-9.
Second trimester prenatal findings in duodenal and esophageal atresia without tracheoesophageal fistula.
Role of the CF Clinician in the Implementation and Maintenance of CF Newborn Screening Programs
Role of the CF Clinician in the Implementation and Maintenance of CF Newborn Screening Programs. 2005.
Summary of Workgroup Meeting on Use of Family History Information in Pediatric Primary Care and Public Health. Pediatrics. 2007; 120(Supplement 2):S87-S100.
Summary of Workgroup Meeting on Use of Family History Information in Pediatric Primary Care and Public Health
Basic Mechanisms of Pediatric Respiratory Disease (Haddad GG, Abman SH, Chernick V, editors)
The role of oxidant injury in the pathogenesis of bronchopulmonary dysplasia. Basic Mechanisms of Pediatric Respiratory Disease (Haddad GG, Abman SH, Chernick V, editors). 2002; 505-517.
The role of oxidant injury in the pathogenesis of bronchopulmonary dysplasia
Davis E, III, Aulak K, Parad RB, Stecklein HP, Eldering E, Hack CE, Kramer J, Strunk RC, Bissler J, Rosen FS.
C1 Inhibitor hinge region mutations may convert the inhibitor to a substrate or may result in the inability to interact with target proteases. Nat Genet. 1992; 1:354-58.
C1 Inhibitor hinge region mutations may convert the inhibitor to a substrate or may result in the inability to interact with target proteases
Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW
Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993 Feb; 2(2):159-63.
Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs.
Incidence And Severity of Retinopathy of Prematurity (Rop) is Reduced in Extremely Low Gestational Age (GA) Newborns (ELGANs) Treated with Recombinant Human Cu/Zn Superoxide Dismutase (rhSOD). Journal of European Pediatrics. 2006.
Incidence And Severity of Retinopathy of Prematurity (Rop) is Reduced in Extremely Low Gestational Age (GA) Newborns (ELGANs) Treated with Recombinant Human Cu/Zn Superoxide Dismutase (rhSOD)
Impairment of adaptive tolerance to oxygen toxicity by systemic immunosuppression. Chest. 1975 Feb; 67(2 Suppl):42S-43S.
Impairment of adaptive tolerance to oxygen toxicity by systemic immunosuppression.
Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis. 2010 Oct; 33(Suppl 2):S255-61.
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.
O'Rourke PP, Crone RK, Vacanti JP, Ware JH, Lillehei CW, Parad RB, Epstein MF
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989 Dec; 84(6):957-63.
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study.
Marihuana and the Lungs: Combined Effects of Marihuana and Alcohol on Pulmonary Host Defense Mechanisms. (Thesis approved for Honors in Biology)
Marihuana and the Lungs: Combined Effects of Marihuana and Alcohol on Pulmonary Host Defense Mechanisms. (Thesis approved for Honors in Biology). 1977.
Borowitz D, Parad RB, Sharp JS, Sabadosa KA, Robinson KA, Rock MJ, Farrell PN, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ.
Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond . J Peds. 2009; 155(6, Supplement 1):S71-S116 .
Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond
Ceyhan-Birsoy O, Murry JB, Machini K, Lebo MS, Yu TW, Fayer S, Genetti CA, Schwartz TS, Agrawal PB, Parad RB, Holm IA, McGuire AL, Green RC, Rehm HL, Beggs AH
Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. Am J Hum Genet. 2019 01 03; 104(1):76-93.
Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project.
Als H, Gilkerson L, Duffy FH, McAnulty GB, Buehler DM, Vandenberg K, Sweet N, Sell E, Parad RB, Ringer SA, Butler SC, Blickman JG, Jones KJ
Journal of developmental and behavioral pediatrics : JDBP
A three-center, randomized, controlled trial of individualized developmental care for very low birth weight preterm infants: medical, neurodevelopmental, parenting, and caregiving effects. J Dev Behav Pediatr. 2003 Dec; 24(6):399-408.
A three-center, randomized, controlled trial of individualized developmental care for very low birth weight preterm infants: medical, neurodevelopmental, parenting, and caregiving effects.
Johnson, L, Keefer, C, Parad, R and O'Brien, S
Neonatology Core Curriculum, Volume I (2005 edition)
Neonatology Core Curriculum, Volume I (2005 edition). 1991.
The Cystic Fibrosis Genetic Analysis Consortium, Population variation of common cystic fibrosis mutations. Hum Mutat. 1994; 4:167-77.
The Cystic Fibrosis Genetic Analysis Consortium, Population variation of common cystic fibrosis mutations
Van Marter L, Allred E, Morey J, Parad R, Vitali S, Kourembanas S
Bilirubin and Bronchopulmonary Dysplasia Among Extremely Low Gestational Age Newborns. PAS. 2006.
Bilirubin and Bronchopulmonary Dysplasia Among Extremely Low Gestational Age Newborns
Cystic Fibrosis Transmembrane Conductance Regulator
Sir Edwin and Lady Manton Professor of Pediatrics
Davis JM, Pilon AL, Shenberger J, Breeze JL, Terrin N, Mazela J, Gulczynska E, Lauterbach R, Parad R
The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity. Pediatr Res. 2019 08; 86(2):254-260.
The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity.
Instructor in Obstetrics, Gynecology and Reproductive Biology
Associate Professor of Orthopedic Surgery
Associate Professor of Emergency Medicine
Langfelder-Schwind E, Raraigh KS, Parad RB
Practice variation of genetic counselor engagement in the cystic fibrosis newborn screen-positive diagnostic resolution process. J Genet Couns. 2019 12; 28(6):1178-1188.
Practice variation of genetic counselor engagement in the cystic fibrosis newborn screen-positive diagnostic resolution process.
Afacan O, Estroff JA, Yang E, Barnewolt CE, Connolly SA, Parad RB, Mulkern RV, Warfield SK, Gholipour A
Topics in magnetic resonance imaging : TMRI
Fetal Echoplanar Imaging: Promises and Challenges. Top Magn Reson Imaging. 2019 Oct; 28(5):245-254.
Fetal Echoplanar Imaging: Promises and Challenges.
Gubbels CS, VanNoy GE, Madden JA, Copenheaver D, Yang S, Wojcik MH, Gold NB, Genetti CA, Stoler J, Parad RB, Roumiantsev S, Bodamer O, Beggs AH, Juusola J, Agrawal PB, Yu TW
Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield. Genet Med. 2020 04; 22(4):736-744.
Prospective, phenotype-driven selection of critically ill neonates for rapid exome sequencing is associated with high diagnostic yield.
Milko LV, Chen F, Chan K, Brower AM, Agrawal PB, Beggs AH, Berg JS, Brenner SE, Holm IA, Koenig BA, Parad RB, Powell CM, Kingsmore SF
FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation. NPJ Genom Med. 2019; 4:32.
FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation.
Tracy SA, Lazow SP, Castro-Aragon IM, Fujii AM, Estroff JA, Parad RB, Staffa SJ, Zurakowski D, Chen C
Journal of the American College of Surgeons
Is Abdominal Sonography a Useful Adjunct to Abdominal Radiography in Evaluating Neonates with Suspected Necrotizing Enterocolitis? J Am Coll Surg. 2020 06; 230(6):903-911.e2.
Is Abdominal Sonography a Useful Adjunct to Abdominal Radiography in Evaluating Neonates with Suspected Necrotizing Enterocolitis?
Smith LD, Bainbridge MN, Parad RB, Bhattacharjee A
Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges. Int J Neonatal Screen. 2020 Jun; 6(2).
Second Tier Molecular Genetic Testing in Newborn Screening for Pompe Disease: Landscape and Challenges.
Mackay ZP, Dukhovny D, Phillips KA, Beggs AH, Green RC, Parad RB, Christensen KD
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing. Value Health. 2020 05; 23(5):559-565.
Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing.
Parad RB, Kaler SG, Mauceli E, Sokolsky T, Yi L, Bhattacharjee A
Molecular genetics and metabolism reports
Targeted next generation sequencing for newborn screening of Menkes disease. Mol Genet Metab Rep. 2020 Sep; 24:100625.
Targeted next generation sequencing for newborn screening of Menkes disease.
FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation. NPJ Genom Med. 2019 Dec 10; 4(1):32.
Beam KS, Lee M, Hirst K, Beam A, Parad RB
Specificity of International Classification of Diseases codes for bronchopulmonary dysplasia: an investigation using electronic health record data and a large insurance database. J Perinatol. 2021 04; 41(4):764-771.
Specificity of International Classification of Diseases codes for bronchopulmonary dysplasia: an investigation using electronic health record data and a large insurance database.
Wojcik MH, Zhang T, Ceyhan-Birsoy O, Genetti CA, Lebo MS, Yu TW, Parad RB, Holm IA, Rehm HL, Beggs AH, Green RC, Agrawal PB
Discordant results between conventional newborn screening and genomic sequencing in the BabySeq Project. Genet Med. 2021 07; 23(7):1372-1375.
Discordant results between conventional newborn screening and genomic sequencing in the BabySeq Project.
Lazow SP, Tracy SA, Staffa SJ, Estroff JA, Parad RB, Castro-Aragon IM, Fujii AM, Zurakowski D, Chen C
Abdominal ultrasound findings contribute to a multivariable predictive risk score for surgical necrotizing enterocolitis: A pilot study. Am J Surg. 2021 Nov; 222(5):1034-1039.
Abdominal ultrasound findings contribute to a multivariable predictive risk score for surgical necrotizing enterocolitis: A pilot study.
Parad RB, Breeze JL, Terrin N, Rogers LK, Salafia CM, Greenough A, Davis JM
Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates. Pediatr Pulmonol. 2021 12; 56(12):3847-3856.
Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.
Pereira S, Smith HS, Frankel LA, Christensen KD, Islam R, Robinson JO, Genetti CA, Blout Zawatsky CL, Zettler B, Parad RB, Waisbren SE, Beggs AH, Green RC, Holm IA, McGuire AL
Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq Project: A Randomized Clinical Trial. JAMA Pediatr. 2021 11 01; 175(11):1132-1141.
Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq Project: A Randomized Clinical Trial.
Lazow SP, Tracy SA, Estroff JA, Parad RB, Castro-Aragon IM, Fujii AM, Staffa SJ, Zurakowski D, Chen C
A role for abdominal ultrasound in discriminating suspected necrotizing enterocolitis in congenital heart disease patients. Pediatr Surg Int. 2022 Feb; 38(2):225-233.
A role for abdominal ultrasound in discriminating suspected necrotizing enterocolitis in congenital heart disease patients.
Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption. Int J Neonatal Screen. 2021 Nov 15; 7(4).
Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption.
Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelines. Pediatr Pulmonol. 2022 04; 57(4):894-902.
Genetic counseling access for parents of newborns who screen positive for cystic fibrosis: Consensus guidelines.
Ahmed S, Odumade OA, van Zalm P, Smolen KK, Fujimura K, Muntel J, Rotunno MS, Winston AB, Steen JA, Parad RB, Van Marter LJ, Kourembanas S, Steen H
Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia. Neonatology. 2022; 119(2):193-203.
Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia.
Armstrong B, Christensen KD, Genetti CA, Parad RB, Robinson JO, Blout Zawatsky CL, Zettler B, Beggs AH, Holm IA, Green RC, McGuire AL, Smith HS, Pereira S
Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study. Front Genet. 2022; 13:867371.
Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study.
An oversight regarding the club cell? Pediatr Pulmonol. 2022 09; 57(9):2252.
Pereira S, Gutierrez AM, Robinson JO, Christensen KD, Genetti CA, Blout Zawatsky CL, Hsu RL, Zettler B, Uveges MK, Parad RB, Beggs AH, Holm IA, Green RC, McGuire AL
Parents' decision-making regarding whether to receive adult-onset only genetic findings for their children: Findings from the BabySeq Project. Genet Med. 2023 03; 25(3):100002.
Parents' decision-making regarding whether to receive adult-onset only genetic findings for their children: Findings from the BabySeq Project.
Mary Ellen Avery Professor of Pediatrics
Green RC, Shah N, Genetti CA, Yu T, Zettler B, Uveges MK, Ceyhan-Birsoy O, Lebo MS, Pereira S, Agrawal PB, Parad RB, McGuire AL, Christensen KD, Schwartz TS, Rehm HL, Holm IA, Beggs AH
Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. Am J Hum Genet. 2023 07 06; 110(7):1034-1045.
Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project.
Armstrong N, Apkon S, Berggren KN, Braun C, Ciafaloni E, Connolly A, Kennedy A, Kuntz N, Mathews K, McGuire M, Parad R, Scavina M, Scharf RJ, Waldrop M
The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report. J Neuromuscul Dis. 2024; 11(2):525-533.
The Early Care (0-3 Years) In Duchenne Muscular Dystrophy Meeting Report.
Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M, Mammoto A, Ingber DE, Van Marter LJ
Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology. 2013; 104(1):56-64.
Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity.
Minten T, Bick S, Adelson S, Gehlenborg N, Amendola LM, Boemer F, Coffey AJ, Encina N, Ferlini A, Kirschner J, Russell BE, Servais L, Sund KL, Taft RJ, Tsipouras P, Zouk H, Bick D, Green RC, Gold NB
Data-driven consideration of genetic disorders for global genomic newborn screening programs. Genet Med. 2025 Jul; 27(7):101443.
Data-driven consideration of genetic disorders for global genomic newborn screening programs.
Glotzbecker MP, Estroff JA, Curtis TA, Kalish LA, Spencer SA, Parad RB, Kasser JR, Mahan ST
Prospective evaluation of a prenatal sonographic clubfoot classification system. Fetal Diagn Ther. 2013; 34(4):236-40.
Prospective evaluation of a prenatal sonographic clubfoot classification system.
Lanehart D, Coyne F, Sheldon Y, Parad RB
Potential Impact of Prenatal Expanded Carrier Screening on the Incidence of Duchenne Muscular Dystrophy in Neonates. Fetal Diagn Ther. 2025 Oct 14; 1-5.
Potential Impact of Prenatal Expanded Carrier Screening on the Incidence of Duchenne Muscular Dystrophy in Neonates.
Langfelder-Schwind E, Basile M, Moyal-Smith R, Polo J, McGinniss MA, Petersen J, Talavera J, Schwind H, Parad RB, Raraigh KS
Increasing Access to Genetic Counselors With Disease-Specific Expertise: Development of a Centralized Cystic Fibrosis Genetic Counseling Telehealth Model. Pediatr Pulmonol. 2025 Dec; 60(12):e71416.
Increasing Access to Genetic Counselors With Disease-Specific Expertise: Development of a Centralized Cystic Fibrosis Genetic Counseling Telehealth Model.
Hale JE, O'Sullivan BP, Parad RB, Dorkin HL, Kremer TM, Vehse NW, Yonker LM, Sawicki GS, Counihan AM, Gerstel-Thompson J, Kumar B, Comeau AM
Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis. Genet Med. 2026 Jan; 28(1):101629.
Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis.
Falk EN, Chrzanowski SM, Coyne F, Sheldon Y, Cherkerzian S, Parad RB
Interpreting Neonatal hyperCKemia Identified Through Duchenne Muscular Dystrophy Newborn Screening: A Predictive Model Based on Maternal, Labor, Delivery and Newborn Factors. Muscle Nerve. 2026 Mar; 73(3):459-470.
Interpreting Neonatal hyperCKemia Identified Through Duchenne Muscular Dystrophy Newborn Screening: A Predictive Model Based on Maternal, Labor, Delivery and Newborn Factors.
Lakshmanan A, Leeman KT, Brodsky D, Parad R
Evaluation of a web-based portal to improve resident education by neonatology fellows. Med Educ Online. 2014; 19:24403.
Evaluation of a web-based portal to improve resident education by neonatology fellows.
Davis JM, Rosenfeld WN, Richter SE, Parad MR, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Tierney J, Horowitz S
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics. 1997 Jul; 100(1):24-30.
Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome.
Indeterminate cystic fibrosis newborn screening results. Pediatr Pulmonol. 2015 Feb; 50(2):209-10.
Indeterminate cystic fibrosis newborn screening results.
Parad RB, Davis JM, Lo J, Thomas M, Marlow N, Calvert S, Peacock JL, Greenough A
Prediction of respiratory outcome in extremely low gestational age infants. Neonatology. 2015; 107(4):241-8.
Prediction of respiratory outcome in extremely low gestational age infants.
Bhattacharjee A, Sokolsky T, Wyman SK, Reese MG, Puffenberger E, Strauss K, Morton H, Parad RB, Naylor EW
Development of DNA confirmatory and high-risk diagnostic testing for newborns using targeted next-generation DNA sequencing. Genet Med. 2015 May; 17(5):337-47.
Development of DNA confirmatory and high-risk diagnostic testing for newborns using targeted next-generation DNA sequencing.
Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, Barben J, Southern KW
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. J Cyst Fibros. 2015 Nov; 14(6):706-13.
Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening.
The Expression of Bacterial Permeability - Increasing Proteina nd Monocyte/Neutrophil Elastase Inhibitor in Newborns of Different Gestational Ages
Study of Innate Defense in Critically Ill Premature Neonates: Measurement of Bactericidal/Permeability - Increasing Protein in the Tracheal Aspirate Derived Neutrophils
Study of Innate Defense In Critically Ill Premature Neonates: Measurementof Bactericidal/Permeability Increasing Protein in the New Tracheal Aspirate-derived Neutrophils
Study of Innate Defense in Critically Il Premature Neonates
Afacan O, Gholipour A, Mulkern RV, Barnewolt CE, Estroff JA, Connolly SA, Parad RB, Bairdain S, Warfield SK
Journal of magnetic resonance imaging : JMRI
Fetal lung apparent diffusion coefficient measurement using diffusion-weighted MRI at 3 Tesla: Correlation with gestational age. J Magn Reson Imaging. 2016 12; 44(6):1650-1655.
Fetal lung apparent diffusion coefficient measurement using diffusion-weighted MRI at 3 Tesla: Correlation with gestational age.
ASSOCIATION OF CFTR MUTATIONS AND BORDERLINE SWEAT TESTS
Parent Education on DNA Testing in the Newborn Screen
Salinas DB, Azen C, Young S, Keens TG, Kharrazi M, Parad RB
Genetic testing and molecular biomarkers
Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length. Genet Test Mol Biomarkers. 2016 Sep; 20(9):496-503.
Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length.
Ceyhan-Birsoy O, Machini K, Lebo MS, Yu TW, Agrawal PB, Parad RB, Holm IA, McGuire A, Green RC, Beggs AH, Rehm HL
A curated gene list for reporting results of newborn genomic sequencing. Genet Med. 2017 07; 19(7):809-818.
A curated gene list for reporting results of newborn genomic sequencing.
Berg JS, Agrawal PB, Bailey DB, Beggs AH, Brenner SE, Brower AM, Cakici JA, Ceyhan-Birsoy O, Chan K, Chen F, Currier RJ, Dukhovny D, Green RC, Harris-Wai J, Holm IA, Iglesias B, Joseph G, Kingsmore SF, Koenig BA, Kwok PY, Lantos J, Leeder SJ, Lewis MA, McGuire AL, Milko LV, Mooney SD, Parad RB, Pereira S, Petrikin J, Powell BC, Powell CM, Puck JM, Rehm HL, Risch N, Roche M, Shieh JT, Veeraraghavan N, Watson MS, Willig L, Yu TW, Urv T, Wise AL
Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017 Feb; 139(2).
Newborn Sequencing in Genomic Medicine and Public Health.
Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, McColley SA
Diagnosis of Cystic Fibrosis in Screened Populations. J Pediatr. 2017 02; 181S:S33-S44.e2.
Diagnosis of Cystic Fibrosis in Screened Populations.
Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D. J Med Genet. 1996 Aug; 33(8):711-3.
Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D.
A sequence variation in intron 17B of the cystic fibrosis transmembrane conductance regulator gene. Hum Mutat. 1992; 1(3):258-9.
A sequence variation in intron 17B of the cystic fibrosis transmembrane conductance regulator gene.
Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement. Pediatrics. 1998 May; 101(5):851-5.
Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement.
Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB
Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004 Jun; 113(6):1573-81.
Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. J Pediatr. 2005 Sep; 147(3 Suppl):S109-13.
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.
Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J Pediatr. 2005 Sep; 147(3 Suppl):S78-82.
Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Parad RB, Gerard CJ, Zurakowski D, Nichols DP, Pier GB
Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun. 1999 Sep; 67(9):4744-50.
Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
McAnulty G, Duffy FH, Butler S, Parad R, Ringer S, Zurakowski D, Als H
Individualized developmental care for a large sample of very preterm infants: health, neurobehaviour and neurophysiology. Acta Paediatr. 2009 Dec; 98(12):1920-6.
Individualized developmental care for a large sample of very preterm infants: health, neurobehaviour and neurophysiology.
Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W
Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics. 2003 Mar; 111(3):469-76.
Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.
Newborn screening for cystic fibrosis. Pediatr Ann. 2003 Aug; 32(8):528-35.
Davis JM, Richter SE, Biswas S, Rosenfeld WN, Parton L, Gewolb IH, Parad R, Carlo W, Couser RJ, Baumgart S, Atluru V, Salerno L, Kassem N
Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase. J Perinatol. 2000 Jun; 20(4):213-6.
Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase.
Evaluation of a web-based portal to improve resident education by neonatology fellows. Med Educ Online. 2014 Jan; 19(1):24403.
McBride J, Parad R, Davis J, Allred L, Zupancic J
Cost analysis on the use of recombinant human superoxide dismutase (rhSOD) at birth in preterm infants to improve pulmonary outcome. PAS. 2005; 57:1232.
Cost analysis on the use of recombinant human superoxide dismutase (rhSOD) at birth in preterm infants to improve pulmonary outcome
Michael P Glotzbecker MD, Judy A Estroff MD, Susan T Mahan MD, MPH, Justin C Bosley, Richard B Parad MD MPH, Samantha A Spencer, MD, James R Kasser MD
Prenatally Diagnosed Clubfeet: Comparing Ultrasonographic Severity with Clinical Outcomes. http://posna.gmetonline.com/ViewPresentation.aspx?subscriptionpackageid=31. 2009.
Prenatally Diagnosed Clubfeet: Comparing Ultrasonographic Severity with Clinical Outcomes
Physiology of Oxygen Radicals (Taylor A, editor)
Increased permeability of isolated rat lungs perfused with an oxygen radical generator (purine-xanthine oxidase) under constant pressure conditions. Physiology of Oxygen Radicals (Taylor A, editor). 1986.
Increased permeability of isolated rat lungs perfused with an oxygen radical generator (purine-xanthine oxidase) under constant pressure conditions
Comeau AM, Accurso FJ, White TB, Campbell PW, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O'Sullivan BP
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics. 2007 Feb; 119(2):e495-518.
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.
Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M
Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr. 2001 Feb; 138(2):198-204.
Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants.
Davis AE, Aulak K, Parad RB, Stecklein HP, Eldering E, Hack CE, Kramer J, Strunk RC, Bissler J, Rosen FS
C1 inhibitor hinge region mutations produce dysfunction by different mechanisms. Nat Genet. 1992 Aug; 1(5):354-8.
C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.
O'Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R
Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype. Pediatrics. 2006 Sep; 118(3):1260-5.
Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype.
Estoff JA, Parad RB, Frigoletto FD, Benacerraf BR
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
The natural history of isolated fetal hydrothorax. Ultrasound Obstet Gynecol. 1992 May 01; 2(3):162-5.
The natural history of isolated fetal hydrothorax.
Glotzbecker M, Estroff JA, Spencer S, Bosley JC, Parad RB, Kasser JR, Mahan ST
Prenatally diagnosed clubfeet: Comparing ultrasonographic severity with objective clinical outcomes. Journal of Pediatric Orthopaedics. 2010; in press.
Prenatally diagnosed clubfeet: Comparing ultrasonographic severity with objective clinical outcomes
Parad R, Comeau A, Soultan Z, Anbar R, Pass K, Caggana M, Dorkin H, Quizon A, Waltz D, Martin M, Schechter M, Borowitz D, Voter K, Ren C, Dozor A, Kaslovsky R, Comber P, O’Sullivan B
Outcomes of a Cohort of Immunoreactive Trypsinogen (IRT)/DNA Cystic Fibrosis Newborn Screening (CFNBS) Positive Infants with R117H as One of Two Detected CFTR Mutations: Worrisome Throat Culture Findings. Pediatr Pulmonology. 2005; S28:256.
Outcomes of a Cohort of Immunoreactive Trypsinogen (IRT)/DNA Cystic Fibrosis Newborn Screening (CFNBS) Positive Infants with R117H as One of Two Detected CFTR Mutations: Worrisome Throat Culture Findings
Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result. J Pediatr. 2005 Sep; 147(3 Suppl):S98-100.
Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.
Bromley B, Parad R, Estroff JA, Benacerraf BR
Fetal lung masses: prenatal course and outcome. J Ultrasound Med. 1995 Dec; 14(12):927-36; quiz p1378.
Fetal lung masses: prenatal course and outcome.
Als H, Duffy FH, McAnulty G, Butler SC, Lightbody L, Kosta S, Weisenfeld NI, Robertson R, Parad RB, Ringer SA, Blickman JG, Zurakowski D, Warfield SK
NIDCAP improves brain function and structure in preterm infants with severe intrauterine growth restriction. J Perinatol. 2012 Oct; 32(10):797-803.
NIDCAP improves brain function and structure in preterm infants with severe intrauterine growth restriction.
Use of Family History Information in Pediatric Primary Care and Public Health, a Workgroup at Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities
Family History and Single Gene Disorders: Cystic Fibrosis. Use of Family History Information in Pediatric Primary Care and Public Health, a Workgroup at Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities. 2006; http://www.cdc.gov/ncbddd/bd/f.
Family History and Single Gene Disorders: Cystic Fibrosis
Newborn Screening for Cystic Fibrosis: Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs. J Pediatr 147(3):. 2005; 147(3 (Supplement 1)):S1-S114 .
Newborn Screening for Cystic Fibrosis: Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs
Glotzbecker MP, Estroff JA, Spencer SA, Bosley JC, Parad RB, Kasser JR, Mahan ST
Prenatally diagnosed clubfeet: comparing ultrasonographic severity with objective clinical outcomes. J Pediatr Orthop. 2010 Sep; 30(6):606-11.
Prenatally diagnosed clubfeet: comparing ultrasonographic severity with objective clinical outcomes.
Manual of Neonatal Care (Cloherty JP, Stark AR, editors)
Chronic Lung Disease (formerly Bronchopulmonary Dysplasia). Manual of Neonatal Care (Cloherty JP, Stark AR, editors). 1991; 237-246.
Chronic Lung Disease (formerly Bronchopulmonary Dysplasia)
Exogenous surfactant therapy in hyaline membrane disease. Semin Perinatol. 1984 Oct; 8(4):272-82.
Exogenous surfactant therapy in hyaline membrane disease.
Prevalence of cystic fibrosis in fetuses with dilated bowel. Radiology. 1992 Jun; 183(3):677-80.
Prevalence of cystic fibrosis in fetuses with dilated bowel.
Neonatology Core Curriculum, Volume II (2008 edition)
Neonatology Core Curriculum, Volume II (2008 edition). 1991.
Ward VL, Barnewolt CE, Estroff JA, Levine D, Mehta TS, Parad RB.
Work-in-Progress for the SPR Millennium Grant: Fetal MR of Chest Masses. Pediatric Radiology. 2003.
Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW
Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics. 1987 Jan; 79(1):31-7.
Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000 Jun; 105(6):1194-201.
Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network.
Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi DW
Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center. Genet Med. 2001 Nov-Dec; 3(6):411-5.
Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center.
Estroff J, Parad R, Stroehla B, Umbach D and Rogan W
Developing Methods for Studying Estrogen-like Effects of Soy Isoflavones in Infants 3: Ultrasound . PAS. 2006.
Developing Methods for Studying Estrogen-like Effects of Soy Isoflavones in Infants 3: Ultrasound
Nathe K, Suter E, Lund C, Parad R, Morey J, Van Marter L, Levy O
Endotoxin-directed innate immunity in tracheal aspirates of critically ill premature human neonates: Mobilization of bactericidal permeability increasing protein (BPI), LPS-Binding Protein, and Soluble CD14. Pediatric Research. 2007.
Endotoxin-directed innate immunity in tracheal aspirates of critically ill premature human neonates: Mobilization of bactericidal permeability increasing protein (BPI), LPS-Binding Protein, and Soluble CD14
Manual of Neonatal Care (Cloherty JP, Eichenwald, EC, Stark AR, editors)
Bronchopulmonary Dysplasia (Chronic Lung Disease). Manual of Neonatal Care (Cloherty JP, Eichenwald, EC, Stark AR, editors). 2003.
Bronchopulmonary Dysplasia (Chronic Lung Disease)
Estroff JA, Parad RB, Teele RL, Benacerraf BR
Echogenic vessels in the fetal thalami and basal ganglia associated with cytomegalovirus infection. J Ultrasound Med. 1992 Dec; 11(12):686-8.
Echogenic vessels in the fetal thalami and basal ganglia associated with cytomegalovirus infection.
Ontogeny of nonimmune defense mechanisms. Semin Perinatol. 1992 Apr; 16(2):97-105.
Ontogeny of nonimmune defense mechanisms.
Parad RB, Allred EN, Rosenfeld WN, Davis JM
Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase. Neonatology. 2012; 102(2):139-44.
Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase.
Parad RB, Comeau A, Dorkin H, Dovey M, Martin T, Gerstle R, O’Sullivan B
Outcome after an initial borderline sweat test in hypertrypsinogenemic infants detected through CF newborn screening. Pediatric Pulmonology. 2003; sup: 222-223.
Outcome after an initial borderline sweat test in hypertrypsinogenemic infants detected through CF newborn screening
Borowitz B, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL Michel SH, Parad RP, White T, Farrell PM, Marshall BC, Accurso FJ.
Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. J Peds. 2009; 155(6, Supplement 1):S71-S116.
Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis
Incidence and Severity of Retinopathy of Prematurity (ROP) is Reduced in Extremely Low Gestational Age (GA) Newborns (ELGANS) Treated with Recombinant Human Cu/Zn Superoxide Dismutase (rhSOD). Pediatric Research. 2007; E-PAS2007:618225.6.
Incidence and Severity of Retinopathy of Prematurity (ROP) is Reduced in Extremely Low Gestational Age (GA) Newborns (ELGANS) Treated with Recombinant Human Cu/Zn Superoxide Dismutase (rhSOD)
Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening. J Cyst Fibros. 2012 May; 11(3):257-60.
Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know. Pediatr Radiol. 2012 Jan; 42 Suppl 1:S92-100.
Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know.
Lang J E, Forbes P J, Parchesky A, Little M, Hale J, Parad R, Comeau A, Waltz D A.
Safety, Feasibility, and Quality Assurance of Sweat Testing in Newborn Infants. Pediatric Pulmonology. 2006.
Safety, Feasibility, and Quality Assurance of Sweat Testing in Newborn Infants
Work-in-Progress for the SPR Millennium Grant: Fetal MR of Chest Masses. The Society for Pediatric Radiology. 2004.
Bronchopulmonary Dysplasia. Manual of Neonatal Care (Cloherty JP, Eichenwald, EC, Stark AR, editors). 2007.
McBride JA, Parad RB, Davis JM, Zheng Z, Zupancic JA
Economic evaluation of recombinant human copper zinc superoxide dismutase administered at birth to premature infants. J Perinatol. 2009 May; 29(5):364-71.
Economic evaluation of recombinant human copper zinc superoxide dismutase administered at birth to premature infants.
Carlson D, McKeen E, Mitchell M, Torres B, Parad R, Comeau AM, O'Sullivan BP
Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care. Pediatr Pulmonol. 2009 May; 44(5):497-502.
Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care.
Nathe KE, Parad R, Van Marter LJ, Lund CA, Suter EE, Hernandez-diaz S, Boush EB, Ikonomu E, Gallington L, Morey JA, Zeman AM, Mcnamara M, Levy O
Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates. Pediatr Res. 2009 Aug; 66(2):191-6.
Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates.
Labrecque M, Parad RB, Gupta M and Hansen A.
Donation after Cardiac Death: The Potential Contribution of an Infant Organ Donor Population. J Pediatr. 2010; in press..
Donation after Cardiac Death: The Potential Contribution of an Infant Organ Donor Population
Chronic Lung Disease. Manual of Neonatal Care (Cloherty JP, Stark AR, editors). 1997; 378-388.
Bromley B, Estroff JA, Sanders SP, Parad R, Roberts D, Frigoletto FD, Benacerraf BR
American journal of obstetrics and gynecology
Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol. 1992 May; 166(5):1473-81.
Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects.
Chiba-Falek O, Parad RB, Kerem E, Kerem B
American journal of respiratory and critical care medicine
Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation. Am J Respir Crit Care Med. 1999 Jun; 159(6):1998-2002.
Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation.
Parad RB, Estrella E, Comeau AM, Hawley P
Attitute toward CF newborn screening after receiving false positive results: Impact of genetic counseling on parents identified as carriers. Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, MO. Pediatr Pulmonol. 2004; S27:226-227.
Attitute toward CF newborn screening after receiving false positive results: Impact of genetic counseling on parents identified as carriers. Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, MO
Steven Keile, Ruth Koepke, Richard Parad, Martin Kharrazi, California CF Newborn Screening Consortium
Impact of IVS8-(TG)m(T)n Haplootype on Immunorreactive Trypsinogen (IRT) and Sweat Chloride (SC) Levels in a Cohort of Hypertrypsinogenemic (HT) Newborns with Genotype DF508/5T Identified by the California (CA) Cystic Fibrosis (CF) Newborn Screen (NBS) . Ped Pulmonol. 2009.
Impact of IVS8-(TG)m(T)n Haplootype on Immunorreactive Trypsinogen (IRT) and Sweat Chloride (SC) Levels in a Cohort of Hypertrypsinogenemic (HT) Newborns with Genotype DF508/5T Identified by the California (CA) Cystic Fibrosis (CF) Newborn Screen (NBS)
Cullen A, Van Marter LJ, Allred EN, Moore M, Parad RB, Sunday ME
Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2002 Apr 15; 165(8):1093-7.
Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia.
Abman S, ed. Bronchopulmnary Dysplasia (Lung Biology in Health and Disease Vol 240, Lenfant C ed.)
The Use of Antioxidants to Prevent or Ameliorate Bronchopulmonary Dysplasia (Chapter 26). Abman S, ed. Bronchopulmnary Dysplasia (Lung Biology in Health and Disease Vol 240, Lenfant C ed.). 2009; 458-471.
The Use of Antioxidants to Prevent or Ameliorate Bronchopulmonary Dysplasia (Chapter 26)
Removal of CFTR mutation R117H from the cystic fibrosis (CF) newborn screening (NBS) mutation panel would decrease detection of atypical CF. Pediatric Academic Societies Meeting. PAS. 2005; 57:2311.
Removal of CFTR mutation R117H from the cystic fibrosis (CF) newborn screening (NBS) mutation panel would decrease detection of atypical CF. Pediatric Academic Societies Meeting
Als H, Duffy, FH, McAnulty G, Fischer CB, Kosta S, Butler SC, Parad RB, Blickman JG, Zurakowski D, Ringer SA
Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) Effective for Preterm Infants with Intrauterine Growth Restriction?. Journal of Perinatology. 2010; In press.
Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) Effective for Preterm Infants with Intrauterine Growth Restriction?